Suppr超能文献

东方药物生物活性成分的酶免疫测定研究。VI. 人参中人参皂苷Rb1的酶免疫测定。

Studies on the enzyme immunoassay of bio-active constituents in oriental medicinal drugs. VI. Enzyme immunoassay of ginsenoside Rb1 from Panax ginseng.

作者信息

Kanaoka M, Kato H, Shimada F, Yano S

机构信息

Department of Natural Products Chemistry, Research Institute for Wakan-Yaku Oriental Medicines, Toyama, Japan.

出版信息

Chem Pharm Bull (Tokyo). 1992 Feb;40(2):314-7. doi: 10.1248/cpb.40.314.

Abstract

Enzyme immunoassay (EIA) of ginsenoside Rb1 (GRb1), one of the glucosides of protopanaxadiol from Panax ginseng, was explored. A carrier protein (bovine serum albumin (BSA)) was coupled to the C-26 position on the unsaturated side chain of the protopanaxadiol moiety to prepare the immunogen. In order to perform bridge heterologous EIA, a label (beta-D-galactosidase) was introduced at C-26 of the saturated side chain to obtain labeled antigen. Anti-GRb1 antisera were elicited in rabbits by immunization with GRb1-BSA conjugate (9). The double antibody method (with goat anti-rabbit IgG antiserum) was used to separate the bound and free GRb1-beta-Gal. A satisfactory standard curve for EIA of GRb1 was obtained in the range of 0.04-10 ng/tube. In a comparison of the assay results obtained by EIA and HPLC, the linear regression equation and correlation coefficient for the two methods were y (EIA) = 9.18x(HPLC)-0.033 and 0.98, respectively. The anti-GRb1 antiserum cross-reacted with GRb2 (21.8%) and GRc (10.6%), which are also constituents of Panax ginseng.

摘要

对人参中原人参二醇的糖苷之一人参皂苷Rb1(GRb1)的酶免疫测定(EIA)进行了研究。将载体蛋白(牛血清白蛋白(BSA))偶联到原人参二醇部分不饱和侧链的C-26位以制备免疫原。为了进行桥联异源EIA,在饱和侧链的C-26位引入标记物(β-D-半乳糖苷酶)以获得标记抗原。用GRb1-BSA偶联物免疫家兔以产生抗GRb1抗血清(9)。采用双抗体法(用山羊抗兔IgG抗血清)分离结合型和游离型GRb1-β-Gal。在0.04-10 ng/管范围内获得了令人满意的GRb1 EIA标准曲线。在比较EIA和HPLC获得的测定结果时,两种方法的线性回归方程和相关系数分别为y(EIA)= 9.18x(HPLC)-0.033和0.98。抗GRb1抗血清与同样为人参成分的GRb2(21.8%)和GRc(10.6%)发生交叉反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验